Cargando…
High-Dose Erythropoietin Population Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
BACKGROUND: High-dose erythropoietin (Epo) is a promising neuroprotective treatment in neonates with hypoxic ischemic encephalopathy (HIE) receiving hypothermia. We evaluated the pharmacokinetics and dose-exposure relationships of high-dose Epo in this population to inform future dosing strategies....
Autores principales: | Frymoyer, Adam, Juul, Sandra E., Massaro, An N., Bammler, Theo K, Wu, Yvonne W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476365/ https://www.ncbi.nlm.nih.gov/pubmed/28099423 http://dx.doi.org/10.1038/pr.2017.15 |
Ejemplares similares
-
Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo
por: Glass, Hannah C., et al.
Publicado: (2023) -
Every 36-hour Gentamicin Dosing in Neonates with Hypoxic Ischemic Encephalopathy Receiving Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2013) -
Theophylline Dosing and Pharmacokinetics for Renal Protection in Neonates with Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2020) -
Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: McAdams, Ryan M., et al.
Publicado: (2020) -
Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial
por: Juul, Sandra E., et al.
Publicado: (2023)